Molecular sieves and related methods and structure directing agents
    1.
    发明授权
    Molecular sieves and related methods and structure directing agents 有权
    分子筛及相关方法和结构指导剂

    公开(公告)号:US08562942B2

    公开(公告)日:2013-10-22

    申请号:US12757894

    申请日:2010-04-09

    IPC分类号: C01B39/04

    摘要: Method for preparing molecular sieves and molecular sieves obtained thereby are described. The method includes preparing a reaction mixture, comprising a structure directing agent, at least one source of at least one oxide of a tetravalent element, optionally, one or more sources of one or more oxides selected from the group consisting of oxides of trivalent elements, pentavalent elements, and mixtures thereof, optionally, at least one source of an element selected from Groups 1 and 2 of the Periodic Table; and optionally, hydroxide ions or fluoride ions, and maintaining the reaction mixture under conditions sufficient to form crystals of the molecular sieve. In the method, various imidazolium cations are used as the structure directing element.

    摘要翻译: 对由此得到的分子筛和分子筛的制备方法进行了说明。 该方法包括制备反应混合物,其包含结构导向剂,至少一种四价元素氧化物的源,任选的一种或多种一种或多种氧化物源,所述氧化物选自三价元素的氧化物, 五价元素及其混合物,任选地,至少一种选自元素周期表第1和2组元素的源; 和任选的氢氧根离子或氟离子,并将反应混合物保持在足以形成分子筛结晶的条件下。 在该方法中,使用各种咪唑阳离子作为结构导向元件。

    MOLECULAR SIEVES AND RELATED METHODS AND STRUCTURE DIRECTING AGENTS
    2.
    发明申请
    MOLECULAR SIEVES AND RELATED METHODS AND STRUCTURE DIRECTING AGENTS 有权
    分子筛和相关方法和结构指导试剂

    公开(公告)号:US20100260665A1

    公开(公告)日:2010-10-14

    申请号:US12757894

    申请日:2010-04-09

    IPC分类号: C01B39/04 C01B39/00

    摘要: Method for preparing molecular sieves and molecular sieves obtained thereby are described. The method includes preparing a reaction mixture, comprising a structure directing agent, at least one source of at least one oxide of a tetravalent element, optionally, one or more sources of one or more oxides selected from the group consisting of oxides of trivalent elements, pentavalent elements, and mixtures thereof, optionally, at least one source of an element selected from Groups 1 and 2 of the Periodic Table; and optionally, hydroxide ions or fluoride ions, and maintaining the reaction mixture under conditions sufficient to form crystals of the molecular sieve. In the method, various imidazolium cations are used as the structure directing element.

    摘要翻译: 对由此得到的分子筛和分子筛的制备方法进行了说明。 该方法包括制备反应混合物,其包含结构导向剂,至少一种四价元素的氧化物源,任选的一种或多种一种或多种氧化物源,其选自三价元素的氧化物, 五价元素及其混合物,任选地,至少一种选自元素周期表第1和2组元素的源; 和任选的氢氧根离子或氟离子,并将反应混合物保持在足以形成分子筛结晶的条件下。 在该方法中,使用各种咪唑阳离子作为结构导向元件。

    Automatic provisioning of power parameters for femtocell
    3.
    发明授权
    Automatic provisioning of power parameters for femtocell 有权
    为毫微微小区自动提供功率参数

    公开(公告)号:US09313752B2

    公开(公告)日:2016-04-12

    申请号:US12123851

    申请日:2008-05-20

    IPC分类号: H04W36/00 H04W52/34

    CPC分类号: H04W52/343

    摘要: Automatic provisioning of an access point base station or femtocell. The method may include the femtocell transmitting first information (e.g., location information, signal measurement information, capability information, etc.) to a service provider (e.g., over an IP network). The femtocell may receive second information from the service provider, where the second information includes one or more operational parameters. The operational parameters may include hand-off parameters, admission policy parameters, PN or scrambling codes, power parameters, and/or other parameters. The femtocell may operate according to the received parameters to provide access for a plurality of access terminals in a local area.

    摘要翻译: 自动提供接入点基站或毫微微小区。 该方法可以包括毫微微小区向服务提供商(例如,通过IP网络)发送第一信息(例如,位置信息,信号测量信息,能力信息等)。 毫微微小区可以从服务提供商接收第二信息,其中第二信息包括一个或多个操作参数。 操作参数可以包括切换参数,准入策略参数,PN或扰码,功率参数和/或其他参数。 毫微微小区可以根据所接收的参数进行操作,以便为局域中的多个接入终端提供接入。

    Cyclodextrin-based polymers for therapeutics delivery
    7.
    发明授权
    Cyclodextrin-based polymers for therapeutics delivery 有权
    用于治疗输送的基于环糊精的聚合物

    公开(公告)号:US08497365B2

    公开(公告)日:2013-07-30

    申请号:US13198403

    申请日:2011-08-04

    IPC分类号: B82Y5/00

    摘要: The present invention relates to novel compositions comprising polymeric moieties covalently attached to therapeutic agents, wherein the therapeutic agent is attached to the polymeric moiety through a tether. By selecting from a variety of tether groups and targeting ligands the polymers present methods for controlled delivery of the therapeutic agents. The invention also relates to methods of treating subjects with the therapeutic compositions described herein.

    摘要翻译: 本发明涉及包含与治疗剂共价连接的聚合物部分的新型组合物,其中治疗剂通过系链连接到聚合物部分。 通过从各种系链组和靶向配体中选择,聚合物呈现用于治疗剂的受控递送的方法。 本发明还涉及用本文所述的治疗组合物治疗受试者的方法。